Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference
By: PR Newswire Association LLC. - 20 Sep 2017Back to overview list

RICHMOND, Calif., Sept. 20, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27th at 10:55 a.m. Eastern Time. The conference is being held in New York from September 25-27, 2017.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-2017-cantor-fitzgerald-global-healthcare-conference-300523025.html

SOURCE Sangamo Therapeutics, Inc.

Related companies:Sangamo BioSciences
Copyright 2017 PR Newswire Association LLC. Back to overview list
to the top ↑